The nasal spray Neffy is the first non-injectable epinephrine to treat the life-threatening allergic response ARS Pharmaceuticals, Inc. The first-ever needle-free alternative to the EpiPen and similar ...

ARS Pharma had high hopes that the FDA on Tuesday would approve its flagship product, a needle-free treatment for adults and children with severe allergic reactions. But instead, the drugmaker was set ...

The Food and Drug Administration has approved ARS Pharmaceuticals’ nasal spray as the first needle-free emergency treatment for potentially fatal allergic reactions, the agency said on Friday. The ...

FDA advisors recommended that the agency approve an intranasal epinephrine product for type I allergic reactions, including anaphylaxis, despite concerns about the lack of clinical efficacy data. On ...

Anaphylaxis (or "anaphylactic shock") is a life-threatening allergic reaction that needs to be treated right away. If you have an anaphylactic reaction, you need a dose of epinephrine (adrenaline) as ...

Biphasic anaphylaxis involves a second anaphylactic reaction that happens after the first has been successfully treated. This may occur up to 72 hours after the initial reaction. Anaphylaxis is a ...

Anaphylaxis is a severe allergic reaction that can affect bodily functions such as breathing, digestion, and circulation. It can be life threatening and requires immediate treatment. Sneezing, ...